For the Inventor, By the Inventor

Enter assignee name

Leiden, Netherlands

Pharming B.v.

USPTO Granted Patents = 14

Forward Citations = 1,046

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Frank R Pieper (7 out of 9 patents)

Rein Strijker (6 out of 7 patents)

Paul J Krimpenfort (6 out of 7 patents)

4. Sang He Lee (5 out of 8 patents)

5. Herbert L Heyneker (5 out of 33 patents)

6. Gerard Platenburg (5 out of 5 patents)

7. Herman A DeBoer (4 out of 4 patents)

8. Jeffrey M Rosen (2 out of 5 patents)

9. Harry H Van Veen (2 out of 3 patents)

10. Harry M Meade (1 out of 22 patents)

11. Richard A Berg (1 out of 56 patents)

12. Juhani Jänne (1 out of 2 patents)

13. Jan Henricus Nuijens (1 out of 3 patents)

14. Robert M Kay (1 out of 34 patents)

15. Herman A Deboer (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 6140552 - Production of recombinant polypeptides by bovine species and transgenic (2000-10-31),

2. 6118045 - Lysosomal proteins produced in the milk of transgenic animals (2000-09-12),

3. 6111165 - Production of human recombinant collagen in the milk of transgenic (2000-08-29),

4. 6066725 - Production of recombinant polypeptides by bovine species and transgenic (2000-05-23),

5. 6013857 - Transgenic bovines and milk from transgenic bovines (2000-01-11),

6. 5994616 - Targeted synthesis of protein in mammary gland of a non-human transgenic (1999-11-30),

7. 5959171 - Method for the production of biologically active polypeptides in a mammal's (1999-09-28),

8. 5919913 - Isolation of lactoferrin from milk (1999-07-06),

9. 5861491 - Isolation of lactoferrin from milk (1999-01-19),

10. 5750172 - Transgenic non human mammal milk (1998-05-12),

11. 5741957 - Transgenic bovine (1998-04-21),

12. 5721367 - Homologous recombination in mammalian cells (1998-02-24),

13. 5633076 - Method of producing a transgenic bovine or transgenic bovine embryo (1997-05-27),

14. 5565362 - DNA sequences to target proteins to the mammary gland for efficient (1996-10-15),

Pharming Group N.V. is a biopharmaceutical company developing innovative protein replacement therapies and precision genetic medicines for rare diseases and unmet medical needs. The company's lead product, RUCONEST, is approved for the treatment of acute attacks of Hereditary Angioedema. Pharming is committed to improving the lives of patients by providing effective treatments and advancing research in the field of biotechnology.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

14 Patents

#16 in Leiden

#482 in Netherlands

#42,168 in the World

Leiden, Netherlands

Pharming B.v.

Forward Citations = 1,046

23 inventors:

Frank R Pieper (7 out of 9 patents)

Rein Strijker (6 out of 7 patents)

Paul J Krimpenfort (6 out of 7 patents)

4. Sang He Lee (5 out of 8 patents)

5. Herbert L Heyneker (5 out of 33 patents)

Please report any incorrect information to [email protected]

Loading…